Synthetic sulfa drugs, the natural antibiotic penicillin, from Penicillium notatum was discovered by Alexander Fleming, the semi-synthetic …show more content…
But, the era of DNA and medicine was mainly stimulated by the elucidation of the double-helical structure of DNA by Watson and Crick in 1953. The ramifications of this discovery in DNA replication, transcription and translation led to a much better understanding of viral replication. This laid the foundation for antiviral drug discovery in subsequent decades as molecular targets in the viral replication cycle began to be identified. The 1950s also saw the discovery of vancomycin, a glycopeptide which was developed much later for use against methicillin-resistant staphylococci infections. The era of recombinant DNA technology and molecular cloning began around the mid-1970s. The PCR (polymerase chain reaction) of the 1980s resulted in major advances in biotechnology that have significant impact in drug discovery. In the 1990s, combinatorial chemistry, high-throughput screening, molecular modeling and bioinformatics contributed to the discovery of newer generation drugs based on genomics and proteomics …show more content…
Such was the birth of QSARs (quantitative structure–activity relationships) followed in the 1980s and 1990s by computer graphics and molecular modeling. but, computer sciences rapidly ceased to be a simple tool in drug discovery and pharmacology [2].
Twenty one century will see further advances in drug discovery that will likely be based, among other areas, such as chemistry and chemical biology, enzyme-based molecular syntheses, advances in cellular biology and microbiology, cell signaling pathways and their consequences, advanced high-throughput screening (HTS), gene and cell therapy, Bioinformatics and Cheminformatics [1].
1.1.2 Drug Design
Drug designing is an intense, lengthy, an inter-disciplinary and time-consuming process [3]. Drug design, sometimes referred to as rational drug design, is the inventive process of finding new medications based on the knowledge of biological targets [4]. Rational drug design can be generally divided into two categories: development of small molecules with desired properties toward targets, biomolecules (proteins or nucleic acids), whose functional roles in cellular processes and 3D structural information are known. This approach in drug design is well established, being applied extensively by the pharmaceutical industries. Another approach is development of small